Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized tria

Abstract:

:From 1990 to 1996, a total of 386 adult patients with early/intermediate Hodgkin disease (HD) were randomly assigned to receive 3 cycles of adriamycin, bleomycin, vinblastine, dacarbazine (an alkylating agent), and methylprednisolone (ABVDm, arm A) or epirubicin, bleomycin, vinblastine, methotrexate, and methylprednisolone (EBVMm, arm E), a combination without alkylating agent. Responding patients received extended field radiation therapy (RT). Postchemotherapy complete remission and 10-year freedom from progression rates were higher in arm A (79.5% and 91.4%) than in arm E (70.4%, P =.04, and 80%, P <.002). HD mortality (HDM), treatment-related mortality (TRM), and overall survival (OS) were similar in both arms (A, 2.1%, 7.5%, and 90.4%; B, 3.9%, 5.5%, and 90.3%). However TRM and OS rates were lower in patients aged 40 years or older (P <.005), reflecting the increasing incidence of background fatal events with increasing age. Finally, event-free survival (EFS) was higher in arm A (84.6%) than in arm E (74.9%, P <.02). In patients aged younger than 40 years in arm A (74%), 10-year EFS and OS rates were 88.9% and 95.4% with HDM and TRM rates as low as 0.7% and 3%. Three courses of ABVDm plus RT are the best available option for treating early or intermediate HD.

journal_name

Blood

journal_title

Blood

authors

le Maignan C,Desablens B,Delwail V,Dib M,Berthou C,Vigier M,Ghandour C,Atmani S,Casassus P,Maisonneuve H,Le Mevel A,Traulle C,Bernard M,Briere J,Colonna P,Andrieu JM

doi

10.1182/blood-2003-05-1611

subject

Has Abstract

pub_date

2004-01-01 00:00:00

pages

58-66

issue

1

eissn

0006-4971

issn

1528-0020

pii

2003-05-1611

journal_volume

103

pub_type

临床试验,杂志文章,多中心研究,随机对照试验

相关文献

BLOOD文献大全
  • A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease.

    abstract::In individuals with sickle cell disease, a variable number of irreversibly sickled cells (ISC) is present that may contribute to the pathophysiology of sickle cell anemia. The present study was undertaken to determine the possible role of membrane lipid peroxidation in the genesis of ISC. After 24 hr of simple aerobic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jain SK,Shohet SB

    更新日期:1984-02-01 00:00:00

  • Stimulation of neutrophil oxidative metabolism by the alternate pathway of complement activation: a mechanism for the spontaneous NBT test.

    abstract::The reduction of nitroblue tetrazolium dye by human neutrophils was measured in the presence of serum in which the complement system had been activated through the alternate pathway by interaction with inulin. Neutrophils incubated with serum inulin supernatants reduced the dye and showed a general increase in oxidati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Strauss RG,Mauer AM,Asbrock T,Spitzer RE,Stitzel AE

    更新日期:1975-06-01 00:00:00

  • A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene.

    abstract::The transcription factor LMO2 is believed to exert its effect through the formation of protein-protein interactions with other DNA-binding factors such as GATA-1 and TAL1. Although LMO2 has been shown to be critical for the formation of the erythroid cell lineage, the gene is also expressed in a number of nonerythroid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2702

    authors: Crable SC,Anderson KP

    更新日期:2003-06-15 00:00:00

  • Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.

    abstract::Chimeric antigen receptor (CAR) T cells targeting CD19 have emerged as a leading engineered T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. The phase 1/2 clinical trials that led to US Food and Drug Administration approval excluded patients with central nervous system (CNS) involvement, due to stri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001694

    authors: Frigault MJ,Dietrich J,Martinez-Lage M,Leick M,Choi BD,DeFilipp Z,Chen YB,Abramson J,Crombie J,Armand P,Nayak L,Panzini C,Riley LS,Gallagher K,Maus MV

    更新日期:2019-09-12 00:00:00

  • Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.

    abstract::Retroviral gene therapy can restore immunity to infants with X-linked severe combined immunodeficiency (XSCID) caused by mutations in the IL2RG gene encoding the common gamma chain (gammac) of receptors for interleukins 2 (IL-2), -4, -7, -9, -15, and -21. We investigated the safety and efficacy of gene therapy as salv...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-11-058933

    authors: Chinen J,Davis J,De Ravin SS,Hay BN,Hsu AP,Linton GF,Naumann N,Nomicos EY,Silvin C,Ulrick J,Whiting-Theobald NL,Malech HL,Puck JM

    更新日期:2007-07-01 00:00:00

  • Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors.

    abstract::RUNX1 is crucial for the regulation of megakaryocyte specification, maturation, and thrombopoiesis. Runx1 possesses 2 promoters: the distal P1 and proximal P2 promoters. The major protein isoforms generated by P1 and P2 are RUNX1C and RUNX1B, respectively, which differ solely in their N-terminal amino acid sequences. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-723635

    authors: Draper JE,Sroczynska P,Leong HS,Fadlullah MZH,Miller C,Kouskoff V,Lacaud G

    更新日期:2017-07-20 00:00:00

  • Chromosomal assignment of the human thrombin receptor gene: localization to region q13 of chromosome 5.

    abstract::A functional thrombin receptor (TR) structurally related to other members of the seven-transmembrane receptor family has been isolated from diverse cellular types intimately involved in the regulation of the thrombotic response. This receptor recapitulates many of the previously identified sequelae of thrombin-mediate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bahou WF,Nierman WC,Durkin AS,Potter CL,Demetrick DJ

    更新日期:1993-09-01 00:00:00

  • Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes.

    abstract::Vorinostat (suberoylanilide hydroxamic acid, SAHA) is a histone deacetylase inhibitor active clinically in cutaneous T-cell lymphoma and preclinically in leukemia. A phase 1 study was conducted to evaluate the safety and activity of oral vorinostat 100 to 300 mg twice or thrice daily for 14 days followed by 1-week res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-098061

    authors: Garcia-Manero G,Yang H,Bueso-Ramos C,Ferrajoli A,Cortes J,Wierda WG,Faderl S,Koller C,Morris G,Rosner G,Loboda A,Fantin VR,Randolph SS,Hardwick JS,Reilly JF,Chen C,Ricker JL,Secrist JP,Richon VM,Frankel SR,Kantarj

    更新日期:2008-02-01 00:00:00

  • New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.

    abstract::The MLLT10 gene, located at 10p13, is a known partner of MLL and PICALM in specific leukemic fusions generated from recurrent 11q23 and 11q14 chromosome translocations. Deep sequencing recently identified NAP1L1/12q21 as another MLLT10 partner in T-cell acute lymphoblastic leukemia (T-ALL). In pediatric T-ALL, we have...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-487256

    authors: Brandimarte L,Pierini V,Di Giacomo D,Borga C,Nozza F,Gorello P,Giordan M,Cazzaniga G,Te Kronnie G,La Starza R,Mecucci C

    更新日期:2013-06-20 00:00:00

  • Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.

    abstract::Regulatory T cells (Tregs) down-regulate immunity and are associated with chronic viral infections, suggesting that their inhibition might be used to treat life-threatening diseases. Using the FrCasE mouse retroviral model, we have recently shown that short mAb-based immunotherapies can induce life-long protective imm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-432153

    authors: Nasser R,Pelegrin M,Plays M,Gros L,Piechaczyk M

    更新日期:2013-02-14 00:00:00

  • Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro.

    abstract::A 53-yr-old man sequentially developed aplastic anemia from phenytoin and carbamazepine. Both compounds undergo metabolism to potentially toxic arene oxide intermediates. We tested the hypothesis that the patient's adverse reactions were due to a defect in detoxification of such metabolites by challenging his peripher...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gerson WT,Fine DG,Spielberg SP,Sensenbrenner LL

    更新日期:1983-05-01 00:00:00

  • Bone modulation in sustained hematopoietic stimulation in mice.

    abstract::To understand the etiology of bone modulation and hypercalcemia observed in granulocytosis of a tumor-bearing animal model and to gain insight into the implication of sustained hematopoietic stimulation on the bone tissue, in vivo responses of normal mouse hematopoietic and bone tissues to long-term injections of reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lee MY,Fukunaga R,Lee TJ,Lottsfeldt JL,Nagata S

    更新日期:1991-05-15 00:00:00

  • Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9

    abstract::Cloned T9-C2 glioma cells transfected with membrane macrophage colony-stimulating factor (mM-CSF) never formed subcutaneous tumors when implanted into Fischer rats, whereas control T9 cells did. The T9-C2 cells were completely killed within 1 day through a mechanism that resembled paraptosis. Vacuolization of the T9-C...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0174

    authors: Chen Y,Douglass T,Jeffes EW,Xu Q,Williams CC,Arpajirakul N,Delgado C,Kleinman M,Sanchez R,Dan Q,Kim RC,Wepsic HT,Jadus MR

    更新日期:2002-08-15 00:00:00

  • The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes.

    abstract::We have used (cryo) electron tomography to provide a 3-dimensional (3D) map of the intracellular membrane organization of human platelets at high spatial resolution. Our study shows that the open canalicular system and dense tubular system are highly intertwined and form close associations in specialized membrane regi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268680

    authors: van Nispen tot Pannerden H,de Haas F,Geerts W,Posthuma G,van Dijk S,Heijnen HF

    更新日期:2010-08-19 00:00:00

  • X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.

    abstract::Chronic granulomatous disease (CGD) is an inherited immunodeficiency resulting from the inability of an individual's phagocytes to produce superoxide anions because of defective NADPH oxidase. The disease may be treated by bone marrow transplantation and as such is a candidate for somatic gene therapy. Two thirds of p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Porter CD,Parkar MH,Levinsky RJ,Collins MK,Kinnon C

    更新日期:1993-10-01 00:00:00

  • Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus.

    abstract::Immune deficiency viruses such as SIV in macaques or HIV-1 in human beings have evolved mechanisms to defeat host immunity that also impact the efficacy of vaccines. A key factor for vaccine protection is whether immune responses elicited by prior immunization remain at levels sufficient to limit disease progression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202655

    authors: Poonia B,Salvato MS,Yagita H,Maeda T,Okumura K,Pauza CD

    更新日期:2009-08-06 00:00:00

  • Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.

    abstract::Ravulizumab (ALXN1210), a new complement C5 inhibitor, provides immediate, complete, and sustained C5 inhibition. This phase 3, open-label study assessed the noninferiority of ravulizumab to eculizumab in complement inhibitor-naive adults with paroxysmal nocturnal hemoglobinuria (PNH). Patients with lactate dehydrogen...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2018-09-876136

    authors: Lee JW,Sicre de Fontbrune F,Wong Lee Lee L,Pessoa V,Gualandro S,Füreder W,Ptushkin V,Rottinghaus ST,Volles L,Shafner L,Aguzzi R,Pradhan R,Schrezenmeier H,Hill A

    更新日期:2019-02-07 00:00:00

  • Ex vivo incubation with growth factors enhances the engraftment of fetal hematopoietic cells transplanted in sheep fetuses.

    abstract::Hematopoietic stem cells (HSC) transplanted in utero are in competition with endogenous HSC; thus, ultimately the graft constitutes a relatively small fraction of total HSC pool. To enhance the engraftment of donor cells in sheep fetuses, we preincubated these cells, ex vivo, for 16 hours at 37 degrees C with the cond...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zanjani ED,Ascensao JL,Harrison MR,Tavassoli M

    更新日期:1992-06-01 00:00:00

  • HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration.

    abstract::HGAL is a newly identified germinal center (GC)-specific gene whose expression by the tumor cells correlates with a favorable prognosis in patients with diffuse large B-cell and classical Hodgkin lymphomas. The function of HGAL is unknown. Previous studies demonstrated that HGAL is dispensable for GC formation, immuno...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-087775

    authors: Lu X,Chen J,Malumbres R,Cubedo Gil E,Helfman DM,Lossos IS

    更新日期:2007-12-15 00:00:00

  • Plasmablasts derive from CD23-negative activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction.

    abstract::The terminal differentiation of B cells into antibody-secreting cells (ASCs) is a critical component of adaptive immune responses. However, it is a very sensitive process, which dysfunctions lead to a great variety of lymphoproliferative neoplasia including germinal center-derived lymphomas. To better characterize the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005083

    authors: Pignarre A,Chatonnet F,Caron G,Haas M,Desmots-Loyer F,Fest T

    更新日期:2020-11-04 00:00:00

  • PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation.

    abstract::Dysregulation of polycomb repressive complex 2 (PRC2) promotes oncogenesis partly through its enzymatic function for inducing trimethylation of histone H3 lysine 27 (H3K27me3). However, it remains to be determined how PRC2 activity is regulated in normal and diseased settings. We here report a PRC2-associated cofactor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000578

    authors: Ren Z,Ahn JH,Liu H,Tsai YH,Bhanu NV,Koss B,Allison DF,Ma A,Storey AJ,Wang P,Mackintosh SG,Edmondson RD,Groen RWJ,Martens AC,Garcia BA,Tackett AJ,Jin J,Cai L,Zheng D,Wang GG

    更新日期:2019-10-03 00:00:00

  • The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression.

    abstract::Interaction of platelets with collagen under conditions of blood flow is a multi-step process with tethering via glycoprotein IbIXV (GPIbIXV) over von Willebrand factor, adhesion by direct interaction with the integrin GPIaIIa, and signaling via GPVI. GPVI can be specifically agonized by cross-linked collagen-related ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-08-2591

    authors: Joutsi-Korhonen L,Smethurst PA,Rankin A,Gray E,IJsseldijk M,Onley CM,Watkins NA,Williamson LM,Goodall AH,de Groot PG,Farndale RW,Ouwehand WH

    更新日期:2003-06-01 00:00:00

  • The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors.

    abstract::The monoclonal antibody STRO-1 identifies clonogenic bone marrow stromal cell progenitors (fibroblast colony-forming units [CFU-F]) in adult human bone marrow. These STRO-1+ CFU-F have previously been shown to give rise to cells with the phenotype of fibroblasts, adipocytes, and smooth muscle cells. In this study, the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gronthos S,Graves SE,Ohta S,Simmons PJ

    更新日期:1994-12-15 00:00:00

  • Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo.

    abstract::All-trans retinoic acid (tRA) and arsenic trioxide (As(2)O(3)) induce non-cross-resistant complete clinical remission in patients with acute promyelocytic leukemia with t(15;17) translocation and target PML-RARalpha, the leukemogenic protein, by different pathways suggesting a possible therapeutic synergism. To evalua...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.1.264

    authors: Jing Y,Wang L,Xia L,Chen GQ,Chen Z,Miller WH,Waxman S

    更新日期:2001-01-01 00:00:00

  • Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.

    abstract::In a prospective multicenter study, 368 acute lymphoblastic leukemia (ALL) patients aged 15 to 65 years were treated with an intensified induction and reinduction regimen; 272 (73.9%) achieved complete remission (CR). The median remission duration (MRD) is 24.3 months, and the probability of being in continuous CR (CC...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hoelzer D,Thiel E,Löffler H,Büchner T,Ganser A,Heil G,Koch P,Freund M,Diedrich H,Rühl H

    更新日期:1988-01-01 00:00:00

  • Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia.

    abstract::Pure red cell aplasia (PRCA) is a rare complication in patients with chronic lymphocytic leukemia (CLL). It is characterized by reticulocytopenia and by an absence of red cell precursors in the bone marrow. Unlike autoimmune hemolytic anemia, which is characterized by an increased number of reticulocytes, positive Coo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.1092

    authors: Ghazal H

    更新日期:2002-02-01 00:00:00

  • 'Role of bone marrow stromal cells in the growth of human multiple myeloma.

    abstract::We have verified the hypothesis that multiple myeloma (MM) may be disseminated by circulating clonogenic cells that selectively home to the bone marrow (BM) to receive the signal(s) leading to proliferation, terminal differentiation, and production of the osteoclast activating factors. Long-term cultures of stromal ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Caligaris-Cappio F,Bergui L,Gregoretti MG,Gaidano G,Gaboli M,Schena M,Zallone AZ,Marchisio PC

    更新日期:1991-06-15 00:00:00

  • Studies of factor IX concentrate therapy in hemophilia.

    abstract::The effects of factor IX concentrate therapy on hemostasis in hemophilia patients were studied by means of the radiometric factor IXa assay, the coupled amidolytic assay for factor VIIa, and coagulant assays for factors II, IX, and X, and antithrombin III. Both activated and unactivated concentrates contained factors ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hultin MB

    更新日期:1983-09-01 00:00:00

  • Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

    abstract::Treatment outcome of acute myeloid leukemia (AML) in elderly patients remains unsatisfactory. It has been shown that the infusion of granulocyte colony-stimulating factor-mobilized donor peripheral blood stem cells (G-PBSCs) can enhance graft-versus-leukemia effects and speed hematopoietic recovery. Fifty-eight AML pa...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2010-06-288506

    authors: Guo M,Hu KX,Yu CL,Sun QY,Qiao JH,Wang DH,Liu GX,Sun WJ,Wei L,Sun XD,Huang YJ,Qiao JX,Dong Z,Ai HS

    更新日期:2011-01-20 00:00:00

  • CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.

    abstract::Cytotoxic T lymphocytes (CTLs) can kill target cells by the granule/exocytosis pathway or the Fas-mediated apoptosis pathway. The sensitivity of chronic lymphocytic leukemia (CLL) B cells to CTL-mediated apoptosis before and after CD40 activation was examined. Resting or CD40-activated CLL cells were found to be equal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chu P,Wierda WG,Kipps TJ

    更新日期:2000-06-15 00:00:00